View in EDS

Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial.

Saved in:
Bibliographic Details
Title: Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial.
Authors: Taieb J; Department of Gastroenterology and Gastrointestinal Oncology, CARPEM Comprehensive Cancer Center, Georges-Pompidou European Hospital, AP-HP, Université Paris-Cité, Paris, France; Centre de Recherche des Cordeliers, INSERM, CNRS, Université Paris-Cité, Sorbonne Université, USPC, Equipe Labellisée Ligue Nationale Contre le Cancer, SIRIC CARPEM, Paris, France. Electronic address: jtaieb75@gmail.com., Modest DP; Department of Hematology, Oncology and Cancer Immunology (CVK), Charité-Universitaetsmedizin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Fakih M; City of Hope Comprehensive Cancer Center, Duarte, USA., Ciardiello F; Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy., Van Cutsem E; University Hospitals Gasthuisberg and University of Leuven (KUL), Leuven, Belgium., Elez E; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, Barcelona, Spain., Gravalos C; Medical Oncology Department, 12 de Octubre University Hospital, Madrid, Spain., Bragagnoli AC; Fundacao Pio Xii Hospital Cancer De Barretos, Barretos, Brazil., Barboux V; Servier International Research Institute, Suresnes, France., Roby L; Servier International Research Institute, Suresnes, France., Amellal N; Servier International Research Institute, Suresnes, France., Prager GW; Medical University Vienna, Vienna, Austria.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Sep 09; Vol. 227, pp. 115644. Date of Electronic Publication: 2025 Jul 12.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40694985
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Taieb+J%22">Taieb J</searchLink>; Department of Gastroenterology and Gastrointestinal Oncology, CARPEM Comprehensive Cancer Center, Georges-Pompidou European Hospital, AP-HP, Université Paris-Cité, Paris, France; Centre de Recherche des Cordeliers, INSERM, CNRS, Université Paris-Cité, Sorbonne Université, USPC, Equipe Labellisée Ligue Nationale Contre le Cancer, SIRIC CARPEM, Paris, France. Electronic address: jtaieb75@gmail.com.<br /><searchLink fieldCode="AU" term="%22Modest+DP%22">Modest DP</searchLink>; Department of Hematology, Oncology and Cancer Immunology (CVK), Charité-Universitaetsmedizin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Fakih+M%22">Fakih M</searchLink>; City of Hope Comprehensive Cancer Center, Duarte, USA.<br /><searchLink fieldCode="AU" term="%22Ciardiello+F%22">Ciardiello F</searchLink>; Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Van+Cutsem+E%22">Van Cutsem E</searchLink>; University Hospitals Gasthuisberg and University of Leuven (KUL), Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Elez+E%22">Elez E</searchLink>; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gravalos+C%22">Gravalos C</searchLink>; Medical Oncology Department, 12 de Octubre University Hospital, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bragagnoli+AC%22">Bragagnoli AC</searchLink>; Fundacao Pio Xii Hospital Cancer De Barretos, Barretos, Brazil.<br /><searchLink fieldCode="AU" term="%22Barboux+V%22">Barboux V</searchLink>; Servier International Research Institute, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22Roby+L%22">Roby L</searchLink>; Servier International Research Institute, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22Amellal+N%22">Amellal N</searchLink>; Servier International Research Institute, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22Prager+GW%22">Prager GW</searchLink>; Medical University Vienna, Vienna, Austria.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2025 Sep 09; Vol. 227, pp. 115644. <i>Date of Electronic Publication: </i>2025 Jul 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40694985
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2025.115644
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 115644
    Titles:
      – TitleFull: Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Taieb J
      – PersonEntity:
          Name:
            NameFull: Modest DP
      – PersonEntity:
          Name:
            NameFull: Fakih M
      – PersonEntity:
          Name:
            NameFull: Ciardiello F
      – PersonEntity:
          Name:
            NameFull: Van Cutsem E
      – PersonEntity:
          Name:
            NameFull: Elez E
      – PersonEntity:
          Name:
            NameFull: Gravalos C
      – PersonEntity:
          Name:
            NameFull: Bragagnoli AC
      – PersonEntity:
          Name:
            NameFull: Barboux V
      – PersonEntity:
          Name:
            NameFull: Roby L
      – PersonEntity:
          Name:
            NameFull: Amellal N
      – PersonEntity:
          Name:
            NameFull: Prager GW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 09
              Text: 2025 Sep 09
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 227
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1